Emerald Advisers, LLC
- SEC CIK
- 0001015083
- Latest filing
- Aug 5, 2026
ACAD holding history
Acadia Pharmaceuticals Inc in every 13F filed by Emerald Advisers, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ACAD overviewAll 13F holders of ACADFull Q2 2026 holdings
- Shares (Q2 2026)
- 0
- Sold out in Q2 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 18
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 0 | $0 | 0.0% | −28,637−100.0% | Sold out | Holders |
| Q1 2026 | 28,637 | $637.5K | <0.1% | −782,560−96.5% | Reduced | Holders |
| Q4 2025 | 811,197 | $21.7M | 0.7% | +241,526+42.4% | Added | Holders |
| Q3 2025 | 569,671 | $12.2M | 0.4% | −22,687−3.8% | Reduced | Holders |
| Q2 2025 | 592,358 | $12.8M | 0.5% | −223,547−27.4% | Reduced | Holders |
| Q1 2025 | 815,905 | $13.6M | 0.6% | −9,164−1.1% | Reduced | Holders |
| Q4 2024 | 825,069 | $15.1M | 0.6% | −5,760−0.7% | Reduced | Holders |
| Q3 2024 | 830,829 | $12.8M | 0.5% | +21,998+2.7% | Added | Holders |
| Q2 2024 | 808,831 | $13.1M | 0.6% | −842,293−51.0% | Reduced | Holders |
| Q1 2024 | 1,651,124 | $30.5M | 1.2% | +5,559+0.3% | Added | Holders |
| Q4 2023 | 1,645,565 | $51.5M | 2.2% | −35,487−2.1% | Reduced | Holders |
| Q3 2023 | 1,681,052 | $35.0M | 1.7% | +64,100+4.0% | Added | Holders |
| Q2 2023 | 1,616,952 | $38.7M | 1.7% | +120,392+8.0% | Added | Holders |
| Q1 2023 | 1,496,560 | $28.2M | 1.4% | +174,414+13.2% | Added | Holders |
| Q4 2022 | 1,322,146 | $21.0M | 1.0% | −7,480−0.6% | Reduced | Holders |
| Q3 2022 | 1,329,626 | $21.8M | 1.1% | +468,877+54.5% | Added | Holders |
| Q2 2022 | 860,749 | $12.1M | 0.6% | +72,011+9.1% | Added | Holders |
| Q1 2022 | 788,738 | $19.1M | 0.7% | +71,420+10.0% | Added | Holders |
| Q4 2021 | 717,318 | $16.7M | 0.6% | +717,318 | New | Holders |